Login
$TER
$323.68 +$14.68 (4.75%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 28, 2026
Q1 FY2026
As of Mar 29, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 28, 2025
Q2 FY2025
As of Jun 29, 2025
Q1 FY2025
As of Mar 30, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 29, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Oct 1, 2023
Q2 FY2023
As of Jul 2, 2023
Q1 FY2023
As of Apr 2, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Oct 2, 2022
Q2 FY2022
As of Jul 3, 2022
Q1 FY2022
As of Apr 3, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Oct 3, 2021
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, less allowance for credit losses of $2,835 and $2,410 at June 28, 2026 and December 31, 2025, respectively
Inventories, net
Prepayments
Other current assets
Current assets held for sale
Total current assets
Property, plant and equipment, net
Operating lease right-of-use assets, net
Marketable securities
Deferred tax assets
Retirement plans assets
Equity method investment
Other assets
Acquired intangible assets, net
Goodwill
Long-term assets held for sale
Total assets
LIABILITIES
Current liabilities:
Accounts payable
Accrued employees' compensation and withholdings
Deferred revenue and customer advances
Other accrued liabilities
Operating lease liabilities
Short-term debt
Income taxes payable
Current debt
Current liabilities held for sale
Total current liabilities
Retirement plans liabilities
Long-term deferred revenue and customer advances
Deferred tax liabilities
Long-term other accrued liabilities
Long-term operating lease liabilities
Long-term incomes taxes payable
Long-term liabilities held for sale
Total liabilities
EQUITY
Common stock, $0.125 par value, 1,000,000 shares authorized; 156,378 and 156,088 shares issued and outstanding at June 28, 2026, and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss (gain)
Retained earnings
Total Teradyne shareholders' equity
Equity attributable to noncontrolling interests
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support